Literature DB >> 28346267

Generalizing Study Results: A Potential Outcomes Perspective.

Catherine R Lesko1, Ashley L Buchanan, Daniel Westreich, Jessie K Edwards, Michael G Hudgens, Stephen R Cole.   

Abstract

Great care is taken in epidemiologic studies to ensure the internal validity of causal effect estimates; however, external validity has received considerably less attention. When the study sample is not a random sample of the target population, the sample average treatment effect, even if internally valid, cannot usually be expected to equal the average treatment effect in the target population. The utility of an effect estimate for planning purposes and decision making will depend on the degree of departure from the true causal effect in the target population due to problems with both internal and external validity. Herein, we review concepts from recent literature on generalizability, one facet of external validity, using the potential outcomes framework. Identification conditions sufficient for external validity closely parallel identification conditions for internal validity, namely conditional exchangeability; positivity; the same distributions of the versions of treatment; no interference; and no measurement error. We also require correct model specification. Under these conditions, we discuss how a version of direct standardization (the g-formula, adjustment formula, or transport formula) or inverse probability weighting can be used to generalize a causal effect from a study sample to a well-defined target population, and demonstrate their application in an illustrative example.

Entities:  

Mesh:

Year:  2017        PMID: 28346267      PMCID: PMC5466356          DOI: 10.1097/EDE.0000000000000664

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  35 in total

1.  Leveraging prognostic baseline variables to gain precision in randomized trials.

Authors:  Elizabeth Colantuoni; Michael Rosenblum
Journal:  Stat Med       Date:  2015-04-14       Impact factor: 2.373

2.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

3.  Estimating causal effects from epidemiological data.

Authors:  Miguel A Hernán; James M Robins
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

4.  How to assess the external validity of therapeutic trials: a conceptual approach.

Authors:  O M Dekkers; E von Elm; A Algra; J A Romijn; J P Vandenbroucke
Journal:  Int J Epidemiol       Date:  2009-04-17       Impact factor: 7.196

5.  Commentary: extending organizational schema for causal effects.

Authors:  Katherine J Hoggatt; Sander Greenland
Journal:  Epidemiology       Date:  2014-01       Impact factor: 4.822

6.  Commentary: External validity of results of randomized trials: disentangling a complex concept.

Authors:  Peter M Rothwell
Journal:  Int J Epidemiol       Date:  2009-09-23       Impact factor: 7.196

7.  Compound treatments, transportability, and the structural causal model: the power and simplicity of causal graphs.

Authors:  Maya L Petersen
Journal:  Epidemiology       Date:  2011-05       Impact factor: 4.822

8.  The use of propensity scores to assess the generalizability of results from randomized trials.

Authors:  Elizabeth A Stuart; Stephen R Cole; Catherine P Bradshaw; Philip J Leaf
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2001-04-01       Impact factor: 2.483

9.  Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available.

Authors:  Miguel A Hernán; James M Robins
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

10.  Covariate adjustment in randomized trials with binary outcomes: targeted maximum likelihood estimation.

Authors:  K L Moore; M J van der Laan
Journal:  Stat Med       Date:  2009-01-15       Impact factor: 2.373

View more
  76 in total

1.  UK Biobank, big data, and the consequences of non-representativeness.

Authors:  Katherine M Keyes; Daniel Westreich
Journal:  Lancet       Date:  2019-03-30       Impact factor: 79.321

2.  Generalisability of an online randomised controlled trial: an empirical analysis.

Authors:  Cheng Wang; Katie R Mollan; Michael G Hudgens; Joseph D Tucker; Heping Zheng; Weiming Tang; Li Ling
Journal:  J Epidemiol Community Health       Date:  2017-11-28       Impact factor: 3.710

3.  New methods for generalizability and transportability: the new norm.

Authors:  Sunni L Mumford; Enrique F Schisterman
Journal:  Eur J Epidemiol       Date:  2019-06-07       Impact factor: 8.082

4.  Systems Modeling to Advance the Promise of Data Science in Epidemiology.

Authors:  Magdalena Cerdá; Katherine M Keyes
Journal:  Am J Epidemiol       Date:  2019-05-01       Impact factor: 4.897

5.  Estimating pollution-attributable mortality at the regional and global scales: challenges in uncertainty estimation and causal inference.

Authors:  Rachel C Nethery; Francesca Dominici
Journal:  Eur Heart J       Date:  2019-05-21       Impact factor: 29.983

Review 6.  From Epidemiologic Knowledge to Improved Health: A Vision for Translational Epidemiology.

Authors:  Michael Windle; Hojoon D Lee; Sarah T Cherng; Catherine R Lesko; Colleen Hanrahan; John W Jackson; Mara McAdams-DeMarco; Stephan Ehrhardt; Stefan D Baral; Gypsyamber D'Souza; David W Dowdy
Journal:  Am J Epidemiol       Date:  2019-12-31       Impact factor: 4.897

7.  The Authors Respond to "Issues With the Consecutive-Pregnancies Approach".

Authors:  Ya-Hui Yu; Lisa M Bodnar; Maria M Brooks; Katherine P Himes; Ashley I Naimi
Journal:  Am J Epidemiol       Date:  2019-07-01       Impact factor: 4.897

8.  When Is a Complete-Case Approach to Missing Data Valid? The Importance of Effect-Measure Modification.

Authors:  Rachael K Ross; Alexander Breskin; Daniel Westreich
Journal:  Am J Epidemiol       Date:  2020-12-01       Impact factor: 4.897

9.  Target Validity and the Hierarchy of Study Designs.

Authors:  Daniel Westreich; Jessie K Edwards; Catherine R Lesko; Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2019-02-01       Impact factor: 4.897

10.  Estimating Human Immunodeficiency Virus (HIV) Prevention Effects in Low-incidence Settings.

Authors:  Jacqueline E Rudolph; Stephen R Cole; Joseph J Eron; Angela D Kashuba; Adaora A Adimora
Journal:  Epidemiology       Date:  2019-05       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.